CAESAREA, Israel and
ATLANTA, April 19, 2017 /PRNewswire/ -- DarioHealth Corp.
(NASDAQ: DRIO), a leading global digital health company with mobile
health and big data solutions, today announced a brand ambassador
partnership with NBA great and Naismith Memorial Basketball Hall of
Famer Dominique Wilkins. The focus
of the partnership is to advance awareness of MyDario, drive growth
of new customers and increase market penetration. The multi-year
agreement encompasses collaboration on social media, digital
marketing and public appearances.
A year after his retirement as a legendary professional
basketball player, Wilkins received devastating news about his
health: he was a type 2 diabetic. With his striking physical
presence on the court and good health during his 16-year
professional career, the discovery left Wilkins in denial. Although
his grandfather and father had both died from diabetes, he never
worried or tried to thwart off the disease because he was in great
shape from basketball.
"Diabetes is a complex disease and I am always striving to stay
ahead with the latest innovations to help me monitor and beat it,"
said Wilkins. "A few months ago, I started using MyDario on a daily
basis to monitor my blood glucose levels. I found the MyDario
plug-in enabling my smartphone to become a glucose meter device to
be extremely easy to set up and use. I really like the compact
design and convenience of making what I already carry with me all
day, my smartphone, into a medical device. The MyDario mobile app
is strong in its ability to manage and analyze the data inputs,
leading to the management of a healthier lifestyle. I am excited to
partner with DarioHealth to help others be more proactive and to
think differently about managing their diabetes."
Erez Raphael, Chief Executive
Officer of DarioHealth, stated, "We are excited about MyDario
partnering with such a beloved and recognizable talent.
Dominique Wilkins is passionate
about his fight and efforts in dealing with diabetes and will
undoubtedly maximize the MyDario brand potential and be a powerful
agent for change. We are honored that Dominique has chosen
DarioHealth to help him in his daily battle with diabetes and
believe he will inspire others to live a healthier life."
Please be sure to follow DarioHealth, MyDario and Dominique Wilkins:
http://www.dominiquewilkins21.com
Facebook:
https://www.facebook.com/USADario/
HumanHighlightFilm21
https://www.facebook.com/HumanHighlightFilm21/
Twitter:
https://twitter.com/my_dario
@DWilkins21
https://twitter.com/DWilkins21
Instagram:
@dominiquewilkins21
https://www.instagram.com/dominiquewilkins21/?hl=en
About Dominque
Wilkins
Dominique
Wilkins is a legendary professional basketball player who
began his career playing for the Atlanta Hawks. Wilkins was a
nine-time NBA All-Star, and one of the all-time elite scoring
machines in NBA history, living up to his college nickname "The
Human Highlight Film." In 2006, Wilkins' career was immortalized
and celebrated with his induction into the Naismith Memorial
Basketball Hall of Fame. Wilkins currently serves as the Hawks'
Vice President of Basketball Operations, where he transfers his
basketball passion and knowledge to the next generation of elite
NBA athletes.
About DarioHealth Corp.
DarioHealth Corp. is a
leading global digital health company serving tens of thousands of
users with dynamic mobile health solutions. We believe people
deserve the best tools to manage their treatment, and harnessing
big data, we have developed a unique way for our users to analyze
and personalize their diabetes management. With our smart diabetes
solution, users have direct access to track and monitor all facets
of diabetes, without having the disease slow them down. The
acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood
glucose meter and native smartphone app gives users an unrivaled
method for self-diabetes management. DarioHealth is headquartered
in Caesarea, Israel with a
regional office in Burlington,
Massachusetts. For more information, visit
http://mydario.investorroom.com/.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. (the "Company") related thereto
contain or may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements that are not statements of historical fact may be deemed
to be forward-looking statements. Without limiting the generality
of the foregoing, words such as "plan," "project," "potential,"
"seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate" or "continue" are intended to identify
forward-looking statements. For example, when the Company
states that the focus of the partnership with Dominique Wilkins is to drive growth of new
customers and increase market penetration, and that the partnership
will maximize the MyDario brand potential, it is using
forward-looking statements. Readers are cautioned that certain
important factors may affect the Company's actual results and could
cause such results to differ materially from any forward-looking
statements that may be made in this news release. Factors that may
affect the Company's results include, but are not limited to,
regulatory approvals, product demand, market acceptance, impact of
competitive products and prices, product development,
commercialization or technological difficulties, the success or
failure of negotiations and trade, legal, social and economic
risks, and the risks associated with the adequacy of existing cash
resources. Additional factors that could cause or contribute to
differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™) may differ
significantly from those set forth in the forward-looking
statements. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
applicable law.
DarioHealth Corporate and Media Contact
Shmuel Herschberg
Marketing Director
shmuel@mydario.com
1-800-896-9062
DarioHealth Investor Relations Contact
Hayden IR
Rob Fink / Brett Maas
DRIO@HaydenIR.com
646-415-8972 / 646-536-7331
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dariohealth-signs-nba-legend-dominique-wilkins-as-brand-ambassador-300441747.html
SOURCE DarioHealth Corp.